The quasispecies nature and biological implications of the hepatitis C virus

Infection, Genetics and Evolution

Volumn 9, Issue 6, 2009, Pages 1158-1167

  Fishman, Sarah L ^a   Branch, Andrea D ^a  

^a MOUNT SINAI SCHOOL OF MEDICINE   (United States)

Author keywords

Compartmentalization; Complexity; Consensus sequence; Diversity; HCV; Interferon resistance; Quasispecies; RNA; Viral persistence

Indexed keywords

ANTIVIRUS AGENT; COMPLEMENTARY DNA; HEPATITIS C VACCINE; INTERFERON; PEGINTERFERON ALPHA; PROTEINASE INHIBITOR; RIBAVIRIN; VIRUS RNA;

ANALYTIC METHOD; ANTIGENICITY; CANCER RISK; CLINICAL TRIAL; CONSENSUS SEQUENCE; DISEASE COURSE; DNA FRAGMENTATION; DNA SEQUENCE; DRUG RESPONSE; DRUG TREATMENT FAILURE; GENE MUTATION; GENETIC CONSERVATION; GENETIC VARIABILITY; GENOTYPE; HEPATITIS C; HEPATITIS C VIRUS; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; LIVER CELL CARCINOMA; LIVER CIRRHOSIS; LIVER TRANSPLANTATION; MATRIX ASSISTED LASER DESORPTION IONIZATION TIME OF FLIGHT MASS SPECTROMETRY; MOLECULAR CLONING; NONHUMAN; NUCLEIC ACID BASE SUBSTITUTION; NUCLEOTIDE SEQUENCE; PERSISTENT VIRUS INFECTION; PHYLOGENY; PRIORITY JOURNAL; REVIEW; RNA REPLICATION; RNA SEQUENCE; RNA STRUCTURE; SEQUENCE ANALYSIS; SEROCONVERSION; SINGLE STRAND CONFORMATION POLYMORPHISM; SUPERINFECTION; TREATMENT DURATION; VIRUS GENE; VIRUS GENOME; VIRUS RESISTANCE; VIRUS STRAIN; VIRUS TRANSCRIPTION; VIRUS TRANSMISSION;

DRUG RESISTANCE, VIRAL; GENETIC TECHNIQUES; GENETIC VARIATION; GENETICS, POPULATION; GENOME, VIRAL; HEPACIVIRUS; HEPATITIS C; HUMANS; RNA, VIRAL; SPECIES SPECIFICITY;

HEPATITIS C VIRUS; RNA VIRUSES;

EID: 70449559210     PISSN: 15671348     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.meegid.2009.07.011     Document Type: Review

References (147)

1. Airaksinen A., Pariente N., Menendez-Arias L., and Domingo E. Curing of foot-and-mouth disease virus from persistently infected cells by ribavirin involves enhanced mutagenesis. Virology 311 (2003) 339-349
2. Anderson J.P., Daifuku R., and Loeb L.A. Viral error catastrophe by mutagenic nucleosides. Annu. Rev. Microbiol. 58 (2004) 183-205
3. Arenas J.I., Gallegos-Orozco J.F., Laskus T., Wilkinson J., Khatib A., Fasola C., Adair D., Radkowski M., Kibler K.V., Nowicki M., Douglas D., Williams J., Netto G., Mulligan D., Klintmalm G., Rakela J., and Vargas H.E. Hepatitis C virus quasi-species dynamics predict progression of fibrosis after liver transplantation. J. Infect. Dis. 189 (2004) 2037-2046
4. Bartels D.J., Zhou Y., Zhang E.Z., Marcial M., Byrn R.A., Pfeiffer T., Tigges A.M., Adiwijaya B.S., Lin C., Kwong A.D., and Kieffer T.L. Natural prevalence of hepatitis C virus variants with decreased sensitivity to NS3.4A protease inhibitors in treatment-naive subjects. J. Infect. Dis. 198 (2008) 800-807
5. Biebricher C.K., and Eigen M. The error threshold. Virus Res. 107 (2005) 117-127
6. Borrego B., Novella I.S., Giralt E., Andreu D., and Domingo E. Distinct repertoire of antigenic variants of foot-and-mouth disease virus in the presence or absence of immune selection. J. Virol. 67 (1993) 6071-6079
7. Bukh J., Miller R.H., and Purcell R.H. Genetic heterogeneity of hepatitis C virus: quasispecies and genotypes. Semin. Liver Dis. 15 (1995) 41-63
8. Bull J.J., Meyers L.A., and Lachmann M. Quasispecies made simple. PLoS Comput. Biol. 1 (2005) e61
9. Cabot B., Martell M., Esteban J.I., Sauleda S., Otero T., Esteban R., Guardia J., and Gomez J. Nucleotide and amino acid complexity of hepatitis C virus quasispecies in serum and liver. J. Virol. 74 (2000) 805-811
10. Canobio S., Guilbert C.M., Troesch M., Samson J., Lemay M., Pelletier V.A., Bernard-Bonnin A.C., Kozielski R., Lapointe N., Martin S.R., and Soudeyns H. Differing patterns of liver disease progression and hepatitis C virus (HCV) quasispecies evolution in children vertically coinfected with HCV and human immunodeficiency virus type 1. J. Clin. Microbiol. 42 (2004) 4365-4369
11. Chambers T.J., Fan X., Droll D.A., Hembrador E., Slater T., Nickells M.W., Dustin L.B., and Dibisceglie A.M. Quasispecies heterogeneity within the E1/E2 region as a pretreatment variable during pegylated interferon therapy of chronic hepatitis C virus infection. J. Virol. 79 (2005) 3071-3083
12. Choo Q.L., Richman K.H., Han J.H., Berger K., Lee C., Dong C., Gallegos C., Coit D., Medina-Selby R., and Barr P.J. Genetic organization and diversity of the hepatitis C virus. Proc. Natl. Acad. Sci. U.S.A. 88 (1991) 2451-2455
13. Comas I., Moya A., and Gonzalez-Candelas F. Validating viral quasispecies with digital organisms: a re-examination of the critical mutation rate. BMC Evol. Biol. 5 (2005) 5
14. de la Torre J.C., and Holland J.J. RNA virus quasispecies populations can suppress vastly superior mutant progeny. J. Virol. 64 (1990) 6278-6281
15. Delwart E.L., and Gordon C.J. Tracking changes in HIV-1 envelope quasispecies using DNA heteroduplex analysis. Methods 12 (1997) 348-354
16. Delwart E.L., Orton S., Parekh B., Dobbs T., Clark K., and Busch M.P. Two percent of HIV-positive U.S. blood donors are infected with non-subtype B strains. AIDS Res. Hum. Retroviruses 19 (2003) 1065-1070
17. Delwart E.L., Shpaer E.G., Louwagie J., McCutchan F.E., Grez M., Rubsamen-Waigmann H., and Mullins J.I. Genetic relationships determined by a DNA heteroduplex mobility assay: analysis of HIV-1 env genes. Science 262 (1993) 1257-1261
18. Dockter J., Evans C.F., Tishon A., and Oldstone M.B. Competitive selection in vivo by a cell for one variant over another: implications for RNA virus quasispecies in vivo. J. Virol. 70 (1996) 1799-1803
19. Domingo E. Quasispecies and the development of new antiviral strategies. Prog. Drug Res. 60 (2003) 133-158
20. Domingo E., Diez J., Martinez M.A., Hernandez J., Holguin A., Borrego B., and Mateu M.G. New observations on antigenic diversification of RNA viruses. Antigenic variation is not dependent on immune selection. J. Gen. Virol. 74 Pt 10 (1993) 2039-2045
21. Domingo E., Escarmis C., Lazaro E., and Manrubia S.C. Quasispecies dynamics and RNA virus extinction. Virus Res. 107 (2005) 129-139
22. Domingo E., Escarmis C., Martinez M.A., Martinez-Salas E., and Mateu M.G. Foot-and-mouth disease virus populations are quasispecies. Curr. Top. Microbiol. Immunol. 176 (1992) 33-47
23. Domingo E., and Gomez J. Quasispecies and its impact on viral hepatitis. Virus Res. 127 (2007) 131-150
24. Domingo E., Martin V., Perales C., Grande-Perez A., Garcia-Arriaza J., and Arias A. Viruses as quasispecies: biological implications. Curr. Top. Microbiol. Immunol. 299 (2006) 51-82
25. Domingo E., Martinez-Salas E., Sobrino F., de la Torre J.C., Portela A., Ortin J., Lopez-Galindez C., Perez-Brena P., Villanueva N., and Najera R. The quasispecies (extremely heterogeneous) nature of viral RNA genome populations: biological relevance-a review. Gene 40 (1985) 1-8
26. Domingo E., Sabo D., Taniguchi T., and Weissmann C. Nucleotide sequence heterogeneity of an RNA phage population. Cell 13 (1978) 735-744
27. Drake J.W., and Holland J.J. Mutation rates among RNA viruses. Proc. Natl. Acad. Sci. U.S.A. 96 (1999) 13910-13913
28. Duarte E.A., Novella I.S., Weaver S.C., Domingo E., Wain-Hobson S., Clarke D.K., Moya A., Elena S.F., de la Torre J.C., and Holland J.J. RNA virus quasispecies: significance for viral disease and epidemiology. Infect. Agents Dis. 3 (1994) 201-214
29. Ducoulombier D., Roque-Afonso A.M., Di Liberto G., Penin F., Kara R., Richard Y., Dussaix E., and Feray C. Frequent compartmentalization of hepatitis C virus variants in circulating B cells and monocytes. Hepatology 39 (2004) 817-825
30. Eigen M. New concepts for dealing with the evolution of nucleic acids. Cold Spring Harb. Symp. Quant. Biol. 52 (1987) 307-320
31. Eigen M. Viral quasispecies. Sci. Am. 269 (1993) 42-49
32. Eigen M. On the nature of virus quasispecies. Trends Microbiol. 4 (1996) 216-218
33. Eigen M. Natural selection: a phase transition?. Biophys. Chem. 85 (2000) 101-123
34. Eigen M., and Schuster P. The Hypercycle - A Principle of Natural Selforganization (1979), Springer-Verlag, Berlin
35. Enomoto N., Sakuma I., Asahina Y., Kurosaki M., Murakami T., Yamamoto C., Izumi N., Marumo F., and Sato C. Comparison of full-length sequences of interferon-sensitive and resistant hepatitis C virus 1b. Sensitivity to interferon is conferred by amino acid substitutions in the NS5A region. J. Clin. Invest. 96 (1995) 224-230
36. Eriksson N., Pachter L., Mitsuya Y., Rhee S.Y., Wang C., Gharizadeh B., Ronaghi M., Shafer R.W., and Beerenwinkel N. Viral population estimation using pyrosequencing. PLoS Comput. Biol. 4 (2008) e1000074
37. Farci P., Quinti I., Farci S., Alter H.J., Strazzera R., Palomba E., Coiana A., Cao D., Casadei A.M., Ledda R., Iorio R., Vegnente A., Diaz G., and Tovo P.A. Evolution of hepatitis C viral quasispecies and hepatic injury in perinatally infected children followed prospectively. Proc. Natl. Acad. Sci. U.S.A. 103 (2006) 8475-8480
38. Farci P., Shimoda A., Coiana A., Diaz G., Peddis G., Melpolder J.C., Strazzera A., Chien D.Y., Munoz S.J., Balestrieri A., Purcell R.H., and Alter H.J. The outcome of acute hepatitis C predicted by the evolution of the viral quasispecies. Science 288 (2000) 339-344
39. Farci P., Strazzera R., Alter H.J., Farci S., Degioannis D., Coiana A., Peddis G., Usai F., Serra G., Chessa L., Diaz G., Balestrieri A., and Purcell R.H. Early changes in hepatitis C viral quasispecies during interferon therapy predict the therapeutic outcome. Proc. Natl. Acad. Sci. U.S.A. 99 (2002) 3081-3086
40. Feliu A., Gay E., Garcia-Retortillo M., Saiz J.C., and Forns X. Evolution of hepatitis C virus quasispecies immediately following liver transplantation. Liver Transpl. 10 (2004) 1131-1139
41. Fishman S.L., Murray J.M., Eng F.J., Walewski J.L., Morgello S., and Branch A.D. Molecular and bioinformatic evidence of hepatitis C virus evolution in brain. J. Infect. Dis. 197 (2008) 597-607
42. Forns X., Purcell R.H., and Bukh J. Quasispecies in viral persistence and pathogenesis of hepatitis C virus. Trends Microbiol. 7 (1999) 402-410
43. Forton D.M., Karayiannis P., Mahmud N., Taylor-Robinson S.D., and Thomas H.C. Identification of unique hepatitis C virus quasispecies in the central nervous system and comparative analysis of internal translational efficiency of brain, liver, and serum variants. J. Virol. 78 (2004) 5170-5183
44. Fried M.W., Shiffman M.L., Reddy K.R., Smith C., Marinos G., Goncales Jr. F.L., Haussinger D., Diago M., Carosi G., Dhumeaux D., Craxi A., Lin A., Hoffman J., and Yu J. Peginterferon alfa-2a plus ribavirin for chronic hepatitis C virus infection. N. Engl. J. Med. 347 (2002) 975-982
45. Gallegos-Orozco J.F., Arenas J.I., Vargas H.E., Kibler K.V., Wilkinson J.K., Nowicki M., Radkowski M., Nasseri J., Rakela J., and Laskus T. Selection of different 5′ untranslated region hepatitis C virus variants during post-transfusion and post-transplantation infection. J. Viral Hepat. 13 (2006) 489-498
46. Gao G., Buskell Z., Seeff L., and Tabor E. Drift in the hypervariable region of the hepatitis C virus during 27 years in two patients. J. Med. Virol. 68 (2002) 60-67
47. Gomez J.C., and Cacho I. Can Nietzsche power relationships be experimentally approached with theoretical and viral quasispecies?. Contrib. Sci. (Rev. Inst. d'Estudis Catalans) 2 (2001) 103-108
48. Gonzalez-Peralta R.P., Qian K., She J.Y., Davis G.L., Ohno T., Mizokami M., and Lau J.Y. Clinical implications of viral quasispecies heterogeneity in chronic hepatitis C. J. Med. Virol. 49 (1996) 242-247
49. Gretch D.R., and Polyak S.J. The quasispecies nature of Hepatitis C Virus: research methods and biological implications. Hepatitis C Virus: Genetic Heterogeneity and Viral Load (1997), GEMHEP John Libbey Eurotext, Paris
50. Gretch D.R., Polyak S.J., Wilson J.J., Carithers Jr. R.L., Perkins J.D., and Corey L. Tracking hepatitis C virus quasispecies major and minor variants in symptomatic and asymptomatic liver transplant recipients. J. Virol. 70 (1996) 7622-7631
51. Hadziyannis S.J., and Koskinas J.S. Differences in epidemiology, liver disease and treatment response among HCV genotypes. Hepatol. Res. 29 (2004) 129-135
52. Hayashi J., Kishihara Y., Yamaji K., Furusyo N., Yamamoto T., Pae Y., Etoh Y., Ikematsu H., and Kashiwagi S. Hepatitis C viral quasispecies and liver damage in patients with chronic hepatitis C virus infection. Hepatology 25 (1997) 697-701
53. Hayashi K. PCR-SSCP: a simple and sensitive method for detection of mutations in the genomic DNA. PCR Methods Appl. 1 (1991) 34-38
54. Hayashi K., and Yandell D.W. How sensitive is PCR-SSCP?. Hum. Mutat. 2 (1993) 338-346
55. He Y., King M.S., Kempf D.J., Lu L., Lim H.B., Krishnan P., Kati W., Middleton T., and Molla A. Relative replication capacity and selective advantage profiles of protease inhibitor-resistant hepatitis C virus (HCV) NS3 protease mutants in the HCV genotype 1b replicon system. Antimicrob. Agents Chemother. 52 (2008) 1101-1110
56. Herring B.L., Tsui R., Peddada L., Busch M., and Delwart E.L. Wide range of quasispecies diversity during primary hepatitis C virus infection. J. Virol. 79 (2005) 4340-4346
57. Hoffmann C., Minkah N., Leipzig J., Wang G., Arens M.Q., Tebas P., and Bushman F.D. DNA bar coding and pyrosequencing to identify rare HIV drug resistance mutations. Nucleic Acids Res. 35 (2007) e91
58. Holland J.J., de la Torre J.C., and Steinhauer D.A. RNA virus populations as quasispecies. Curr. Top. Microbiol. Immunol. 176 (1992) 1-20
59. Holland J.J., Domingo E., de la Torre J.C., and Steinhauer D.A. Mutation frequencies at defined single codon sites in vesicular stomatitis virus and poliovirus can be increased only slightly by chemical mutagenesis. J. Virol. 64 (1990) 3960-3962
60. Holmes E.C. Error thresholds and the constraints to RNA virus evolution. Trends Microbiol. 11 (2003) 543-546
61. Holmes E.C., and Moya A. Is the quasispecies concept relevant to RNA viruses?. J. Virol. 76 (2002) 460-465
62. Honda M., Kaneko S., Sakai A., Unoura M., Murakami S., and Kobayashi K. Degree of diversity of hepatitis C virus quasispecies and progression of liver disease. Hepatology 20 (1994) 1144-1151
63. Hongyo T., Buzard G.S., Calvert R.J., and Weghorst C.M. 'Cold SSCP': a simple, rapid and non-radioactive method for optimized single-strand conformation polymorphism analyses. Nucleic Acids Res. 21 (1993) 3637-3642
64. Jang S.J., Wang L.F., Radkowski M., Rakela J., and Laskus T. Differences between hepatitis C virus 5′ untranslated region quasispecies in serum and liver. J. Gen. Virol. 80 Pt 3 (1999) 711-716
65. Jenkins G.M., Worobey M., Woelk C.H., and Holmes E.C. Evidence for the non-quasispecies evolution of RNA viruses [corrected]. Mol. Biol. Evol. 18 (2001) 987-994
66. Kamp C., and Bornholdt S. Coevolution of quasispecies: B-cell mutation rates maximize viral error catastrophes. Phys. Rev. Lett. 88 (2002) 068104
67. Kimura M. Preponderance of synonymous changes as evidence for the neutral theory of molecular evolution. Nature 267 (1977) 275-276
68. Kohlstaedt, L.A., Wang, J., Rice, P.A., Friedman, J.M., Steitz, T.A., 2009. The structure of HIV-1 reverse transcriptase. 223-249.
69. Koizumi K., Enomoto N., Kurosaki M., Murakami T., Izumi N., Marumo F., and Sato C. Diversity of quasispecies in various disease stages of chronic hepatitis C virus infection and its significance in interferon treatment. Hepatology 22 (1995) 30-35
70. Kryazhimskiy S., and Plotkin J.B. The population genetics of dN/dS. PLoS Genet. 4 (2008) e1000304
71. Kudo T., Yanase Y., Ohshiro M., Yamamoto M., Morita M., Shibata M., and Morishima T. Analysis of mother-to-infant transmission of hepatitis C virus: quasispecies nature and buoyant densities of maternal virus populations. J. Med. Virol. 51 (1997) 225-230
72. Kukita Y., Tahira T., Sommer S.S., and Hayashi K. SSCP analysis of long DNA fragments in low pH gel. Hum. Mutat. 10 (1997) 400-407
73. Kumar D., Malik A., Asim M., Chakravarti A., Das R.H., and Kar P. Response of combination therapy on viral load and disease severity in chronic hepatitis C. Dig. Dis. Sci. 53 (2008) 1107-1113
74. Kumar U., Monjardino J., and Thomas H.C. Hypervariable region of hepatitis C virus envelope glycoprotein (E2/NS1) in an agammaglobulinemic patient. Gastroenterology 106 (1994) 1072-1075
75. Laporte J., Bain C., Maurel P., Inchauspe G., Agut H., and Cahour A. Differential distribution and internal translation efficiency of hepatitis C virus quasispecies present in dendritic and liver cells. Blood 101 (2003) 52-57
76. Laporte J., Malet I., Andrieu T., Thibault V., Toulme J.J., Wychowski C., Pawlotsky J.M., Huraux J.M., Agut H., and Cahour A. Comparative analysis of translation efficiencies of hepatitis C virus 5′ untranslated regions among intraindividual quasispecies present in chronic infection: opposite behaviors depending on cell type. J. Virol. 74 (2000) 10827-10833
77. Laskus T., Radkowski M., Wang L.F., Jang S.J., Vargas H., and Rakela J. Hepatitis C virus quasispecies in patients infected with HIV-1: correlation with extrahepatic viral replication. Virology 248 (1998) 164-171
78. Laskus T., Wang L.F., Rakela J., Vargas H., Pinna A.D., Tsamandas A.C., Demetris A.J., and Fung J. Dynamic behavior of hepatitis C virus in chronically infected patients receiving liver graft from infected donors. Virology 220 (1996) 171-176
79. Lopez-Labrador F.X., Ampurdanes S., Gimenez-Barcons M., Guilera M., Costa J., Jimenez de Anta M.T., Sanchez-Tapias J.M., Rodes J., and Saiz J.C. Relationship of the genomic complexity of hepatitis C virus with liver disease severity and response to interferon in patients with chronic HCV genotype 1b infection [correction of interferon]. Hepatology 29 (1999) 897-903
80. Manns M.P., McHutchison J.G., Gordon S.C., Rustgi V.K., Shiffman M., Reindollar R., Goodman Z.D., Koury K., Ling M., and Albrecht J.K. Peginterferon alfa-2b plus ribavirin compared with interferon alfa-2b plus ribavirin for initial treatment of chronic hepatitis C: a randomised trial. Lancet 358 (2001) 958-965
81. Margulies M., Egholm M., Altman W.E., Attiya S., Bader J.S., Bemben L.A., Berka J., Braverman M.S., Chen Y.J., Chen Z., Dewell S.B., Du L., Fierro J.M., Gomes X.V., Godwin B.C., He W., Helgesen S., Ho C.H., Irzyk G.P., Jando S.C., Alenquer M.L., Jarvie T.P., Jirage K.B., Kim J.B., Knight J.R., Lanza J.R., Leamon J.H., Lefkowitz S.M., Lei M., Li J., Lohman K.L., Lu H., Makhijani V.B., McDade K.E., McKenna M.P., Myers E.W., Nickerson E., Nobile J.R., Plant R., Puc B.P., Ronan M.T., Roth G.T., Sarkis G.J., Simons J.F., Simpson J.W., Srinivasan M., Tartaro K.R., Tomasz A., Vogt K.A., Volkmer G.A., Wang S.H., Wang Y., Weiner M.P., Yu P., Begley R.F., and Rothberg J.M. Genome sequencing in microfabricated high-density picolitre reactors. Nature 437 (2005) 376-380
82. Martell M., Esteban J.I., Quer J., Genesca J., Weiner A., Esteban R., Guardia J., and Gomez J. Hepatitis C virus (HCV) circulates as a population of different but closely related genomes: quasispecies nature of HCV genome distribution. J. Virol. 66 (1992) 3225-3229
83. McCaughan G.W., Laskus T., and Vargas H.E. Hepatitis C virus quasispecies: misunderstood and mistreated?. Liver Transpl. 9 (2003) 1048-1052
84. McGarvey M.J., Iqbal M., Nastos T., and Karayiannis P. Restricted quasispecies variation following infection with the GB virus B. Virus Res. 135 (2008) 181-186
85. Melcher U. The '30K' superfamily of viral movement proteins. J. Gen. Virol. 81 (2000) 257-266
86. Moreau I., Levis J., Crosbie O., Kenny-Walsh E., and Fanning L.J. Correlation between pre-treatment quasispecies complexity and treatment outcome in chronic HCV genotype 3a. Virol. J. 5 (2008) 78
87. Moreno G.J., del Campo T.S., Moraleda G.G., Garcia G.M., de Vicente L.E., Nuno Vazquez-Garza J., Fortun A.J., Martin P., and Barcena M.R. Analysis of hepatitis C viral quasispecies in liver transplantation. Transplant. Proc. 35 (2003) 1838-1840
88. Moya A., Elena S.F., Bracho A., Miralles R., and Barrio E. The evolution of RNA viruses: a population genetics view. Proc. Natl. Acad. Sci. U.S.A. 97 (2000) 6967-6973
89. Murakami J., Okamoto M., Miyata H., Nagata I., Shiraki K., and Hino S. Evolution in the hypervariable region of hepatitis C virus in infants after vertical transmission. Pediatr. Res. 48 (2000) 450-456
90. Naito M., Hayashi N., Moribe T., Hagiwara H., Mita E., Kanazawa Y., Kasahara A., Fusamoto H., and Kamada T. Hepatitis C viral quasispecies in hepatitis C virus carriers with normal liver enzymes and patients with type C chronic liver disease. Hepatology 22 (1995) 407-412
91. Navas S., Martin J., Quiroga J.A., Castillo I., and Carreno V. Genetic diversity and tissue compartmentalization of the hepatitis C virus genome in blood mononuclear cells, liver, and serum from chronic hepatitis C patients. J. Virol. 72 (1998) 1640-1646
92. Ni Y.H., Chang M.H., Chen P.J., Lin H.H., and Hsu H.Y. Evolution of hepatitis C virus quasispecies in mothers and infants infected through mother-to-infant transmission. J. Hepatol. 26 (1997) 967-974
93. Nowak M.A., and May R.M. Coexistence and competition in HIV infections. J. Theor. Biol. 159 (1992) 329-342
94. Orita M., Suzuki Y., Sekiya T., and Hayashi K. Rapid and sensitive detection of point mutations and DNA polymorphisms using the polymerase chain reaction. Genomics 5 (1989) 874-879
95. Pawlotsky J.M. The nature of interferon-alpha resistance in hepatitis C virus infection. Curr. Opin. Infect. Dis. 16 (2003) 587-592
96. Pawlotsky J.M., Germanidis G., Frainais P.O., Bouvier M., Soulier A., Pellerin M., and Dhumeaux D. Evolution of the hepatitis C virus second envelope protein hypervariable region in chronically infected patients receiving alpha interferon therapy. J. Virol. 73 (1999) 6490-6499
97. Pawlotsky J.M., Germanidis G., Neumann A.U., Pellerin M., Frainais P.O., and Dhumeaux D. Interferon resistance of hepatitis C virus genotype 1b: relationship to nonstructural 5A gene quasispecies mutations. J. Virol. 72 (1998) 2795-2805
98. Pawlotsky J.M., Pellerin M., Bouvier M., Roudot-Thoraval F., Germanidis G., Bastie A., Darthuy F., Remire J., Soussy C.J., and Dhumeaux D. Genetic complexity of the hypervariable region 1 (HVR1) of hepatitis C virus (HCV): influence on the characteristics of the infection and responses to interferon alfa therapy in patients with chronic hepatitis C. J. Med. Virol. 54 (1998) 256-264
99. Pellerin M., Lopez-Aguirre Y., Penin F., Dhumeaux D., and Pawlotsky J.M. Hepatitis C virus quasispecies variability modulates nonstructural protein 5A transcriptional activation, pointing to cellular compartmentalization of virus-host interactions. J. Virol. 78 (2004) 4617-4627
100. Polyak S.J., Faulkner G., Carithers Jr. R.L., Corey L., and Gretch D.R. Assessment of hepatitis C virus quasispecies heterogeneity by gel shift analysis: correlation with response to interferon therapy. J. Infect. Dis. 175 (1997) 1101-1107
101. Polyak S.J., McArdle S., Liu S.L., Sullivan D.G., Chung M., Hofgartner W.T., Carithers Jr. R.L., McMahon B.J., Mullins J.I., Corey L., and Gretch D.R. Evolution of hepatitis C virus quasispecies in hypervariable region 1 and the putative interferon sensitivity-determining region during interferon therapy and natural infection. J. Virol. 72 (1998) 4288-4296
102. Poss M., Rodrigo A.G., Gosink J.J., Learn G.H., de Vange P.D., Martin Jr. H.L., Bwayo J., Kreiss J.K., and Overbaugh J. Evolution of envelope sequences from the genital tract and peripheral blood of women infected with clade A human immunodeficiency virus type 1. J. Virol. 72 (1998) 8240-8251
103. Power J.P., Lawlor E., Davidson F., Holmes E.C., Yap P.L., and Simmonds P. Molecular epidemiology of an outbreak of infection with hepatitis C virus in recipients of anti-D immunoglobulin. Lancet 345 (1995) 1211-1213
104. Prince A.M., Pawlotsky J.M., Soulier A., Tobler L., Brotman B., Pfahler W., Lee D.H., Li L., and Shata M.T. Hepatitis C virus replication kinetics in chimpanzees with self-limited and chronic infections. J. Viral Hepat. 11 (2004) 236-242
105. Puig-Basagoiti F., Forns X., Furcic I., Ampurdanes S., Gimenez-Barcons M., Franco S., Sanchez-Tapias J.M., and Saiz J.C. Dynamics of hepatitis C virus NS5A quasispecies during interferon and ribavirin therapy in responder and non-responder patients with genotype 1b chronic hepatitis C. J. Gen. Virol. 86 (2005) 1067-1075
106. Puig-Basagoiti F., Saiz J.C., Forns X., Ampurdanes S., Gimenez-Barcons M., Franco S., Sanchez-Fueyo A., Costa J., Sanchez-Tapias J.M., and Rodes J. Influence of the genetic heterogeneity of the ISDR and PePHD regions of hepatitis C virus on the response to interferon therapy in chronic hepatitis C. J. Med. Virol. 65 (2001) 35-44
107. Qin H., Shire N.J., Keenan E.D., Rouster S.D., Eyster M.E., Goedert J.J., Koziel M.J., and Sherman K.E. HCV quasispecies evolution: association with progression to end-stage liver disease in hemophiliacs infected with HCV or HCV/HIV. Blood 105 (2005) 533-541
108. Quesnel-Vallieres M., Lemay M., Lapointe N., Martin S.R., and Soudeyns H. HCV quasispecies evolution during treatment with interferon alfa-2b and ribavirin in two children coinfected with HCV and HIV-1. J. Clin. Virol. 43 (2008) 236-240
109. Radkowski M., Wilkinson J., Nowicki M., Adair D., Vargas H., Ingui C., Rakela J., and Laskus T. Search for hepatitis C virus negative-strand RNA sequences and analysis of viral sequences in the central nervous system: evidence of replication. J. Virol. 76 (2002) 600-608
110. Ray S.C., Fanning L., Wang X.H., Netski D.M., Kenny-Walsh E., and Thomas D.L. Divergent and convergent evolution after a common-source outbreak of hepatitis C virus. J. Exp. Med. 201 (2005) 1753-1759
111. Rocha E.P., Smith J.M., Hurst L.D., Holden M.T., Cooper J.E., Smith N.H., and Feil E.J. Comparisons of dN/dS are time dependent for closely related bacterial genomes. J. Theor. Biol. 239 (2006) 226-235
112. Roque Afonso A.M., Jiang J., Penin F., Tareau C., Samuel D., Petit M.A., Bismuth H., Dussaix E., and Feray C. Nonrandom distribution of hepatitis C virus quasispecies in plasma and peripheral blood mononuclear cell subsets. J. Virol. 73 (1999) 9213-9221
113. Roque-Afonso A.M., Ducoulombier D., Di Liberto G., Kara R., Gigou M., Dussaix E., Samuel D., and Feray C. Compartmentalization of hepatitis C virus genotypes between plasma and peripheral blood mononuclear cells. J. Virol. 79 (2005) 6349-6357
114. Rothman A.L., Morishima C., Bonkovsky H.L., Polyak S.J., Ray R., Di Bisceglie A.M., Lindsay K.L., Malet P.F., Chang M., Gretch D.R., Sullivan D.G., Bhan A.K., Wright E.C., and Koziel M.J. Associations among clinical, immunological, and viral quasispecies measurements in advanced chronic hepatitis C. Hepatology 41 (2005) 617-625
115. Saiz J.C., Lopez-Labrador F.X., Ampurdanes S., Dopazo J., Forns X., Sanchez-Tapias J.M., and Rodes J. The prognostic relevance of the nonstructural 5A gene interferon sensitivity determining region is different in infections with genotype 1b and 3a isolates of hepatitis C virus. J. Infect. Dis. 177 (1998) 839-847
116. Salmeron J., Casado J., Rueda P.M., Lafuente V., Diago M., Romero-Gomez M., Palacios A., Leon J., Gila A., Quiles R., Rodriguez L., and Ruiz-Extremera A. Quasispecies as predictive factor of rapid, early and sustained virological responses in chronic hepatitis C, genotype 1, treated with peginterferon-ribavirin. J. Clin. Virol. 41 (2008) 264-269
117. Sarrazin C., Herrmann E., Bruch K., and Zeuzem S. Hepatitis C virus nonstructural 5A protein and interferon resistance: a new model for testing the reliability of mutational analyses. J. Virol. 76 (2002) 11079-11090
118. Sarrazin C., Kieffer T.L., Bartels D., Hanzelka B., Muh U., Welker M., Wincheringer D., Zhou Y., Chu H.M., Lin C., Weegink C., Reesink H., Zeuzem S., and Kwong A.D. Dynamic hepatitis C virus genotypic and phenotypic changes in patients treated with the protease inhibitor telaprevir. Gastroenterology 132 (2007) 1767-1777
119. Sarrazin C., Kornetzky I., Ruster B., Lee J.H., Kronenberger B., Bruch K., Roth W.K., and Zeuzem S. Mutations within the E2 and NS5A protein in patients infected with hepatitis C virus type 3a and correlation with treatment response. Hepatology 31 (2000) 1360-1370
120. Schvoerer E., Soulier E., Royer C., Renaudin A.C., Thumann C., Fafi-Kremer S., Brignon N., Doridot S., Meyer N., Pinson P., Ellero B., Woehl-Jaegle M.L., Meyer C., Wolf P., Zachary P., Baumert T., and Stoll-Keller F. Early evolution of hepatitis C virus (HCV) quasispecies after liver transplant for HCV-related disease. J. Infect. Dis. 196 (2007) 528-536
121. Shimizu Y.K., Igarashi H., Kanematu T., Fujiwara K., Wong D.C., Purcell R.H., and Yoshikura H. Sequence analysis of the hepatitis C virus genome recovered from serum, liver, and peripheral blood mononuclear cells of infected chimpanzees. J. Virol. 71 (1997) 5769-5773
122. Simen B.B., Simons J.F., Hullsiek K.H., Novak R.M., Macarthur R.D., Baxter J.D., Huang C., Lubeski C., Turenchalk G.S., Braverman M.S., Desany B., Rothberg J.M., Egholm M., and Kozal M.J. Low-abundance drug-resistant viral variants in chronically HIV-infected, antiretroviral treatment-naive patients significantly impact treatment outcomes. J. Infect. Dis. 199 (2009) 693-701
123. Simmonds P. Variability of hepatitis C virus. Hepatology 21 (1995) 570-583
124. Sookoian S., Flichman D., Castano G., Frider B., and Campos R. Relationship between diversity of hepatitis C quasispecies and histological severity of liver disease. Medicina (B Aires) 60 (2000) 587-590
125. Steinhauer D.A., de la Torre J.C., Meier E., and Holland J.J. Extreme heterogeneity in populations of vesicular stomatitis virus. J. Virol. 63 (1989) 2072-2080
126. Steinhauer D.A., Domingo E., and Holland J.J. Lack of evidence for proofreading mechanisms associated with an RNA virus polymerase. Gene 122 (1992) 281-288
127. Steinhauer D.A., and Holland J.J. Rapid evolution of RNA viruses. Annu. Rev. Microbiol. 41 (1987) 409-433
128. Sugitani M., and Shikata T. Comparison of amino acid sequences in hypervariable region-1 of hepatitis C virus clones between human inocula and the infected chimpanzee sera. Virus Res. 56 (1998) 177-182
129. Thelu M.A., Baud M., Leroy V., Seigneurin J.M., and Zarski J.P. Dynamics of viral quasispecies during interferon therapy in non responder chronic hepatitis C patients. J. Clin. Virol. 22 (2001) 125-131
130. Thompson A.J., and McHutchison J.G. Review article: investigational agents for chronic hepatitis C. Aliment. Pharmacol. Ther. 29 (2009) 689-705
131. Toyoda H., Fukuda Y., Koyama Y., Takamatsu J., Saito H., and Hayakawa T. Effect of immunosuppression on composition of quasispecies population of hepatitis C virus in patients with chronic hepatitis C coinfected with human immunodeficiency virus. J. Hepatol. 26 (1997) 975-982
132. Ueda E., Enomoto N., Sakamoto N., Hamano K., Sato C., Izumi N., and Watanabe M. Changes of HCV quasispecies during combination therapy with interferon and ribavirin. Hepatol. Res. 29 (2004) 89-96
133. Umetsu Y., Sugawara K., Nishimura H., Hongo S., Matsuzaki M., Kitame F., and Nakamura K. Selection of antigenically distinct variants of influenza C viruses by the host cell. Virology 189 (1992) 740-744
134. Vallet S., Gouriou S., Nkontchou G., Hotta H., Vilerio M., Legrand-Quillien M.C., Beaugrand M., Trinchet J.C., Nousbaum J.B., Deny P., Gaudy C., Goudeau A., Picard B., and Payan C. Is hepatitis C virus NS3 protease quasispecies heterogeneity predictive of progression from cirrhosis to hepatocellular carcinoma?. J. Viral Hepat. 14 (2007) 96-106
135. Vargas H.E., Laskus T., Radkowski M., Wilkinson J., Balan V., Douglas D.D., Harrison M.E., Mulligan D.C., Olden K., Adair D., and Rakela J. Detection of hepatitis C virus sequences in brain tissue obtained in recurrent hepatitis C after liver transplantation. Liver Transpl. 8 (2002) 1014-1019
136. Veillon P., Payan C., Guillou-Guillemette H., Gaudy C., and Lunel F. Quasispecies evolution in NS5A region of hepatitis C virus genotype 1b during interferon or combined interferon-ribavirin therapy. World J. Gastroenterol. 13 (2007) 1195-1203
137. Vera-Otarola J., Barria M.I., Leon U., Carvallo P., Soza A., and Lopez-Lastra M. Is single-strand conformation polymorphism analysis of the full 5′ untranslated region an adequate approach to study Hepatitis C virus quasispecies distribution?. J. Virol. (2009)
138. Vignuzzi M., Stone J.K., Arnold J.J., Cameron C.E., and Andino R. Quasispecies diversity determines pathogenesis through cooperative interactions in a viral population. Nature 439 (2006) 344-348
139. Wain-Hobson S. Human immunodeficiency virus type 1 quasispecies in vivo and ex vivo. Curr. Top. Microbiol. Immunol. 176 (1992) 181-193
140. Wang C., Mitsuya Y., Gharizadeh B., Ronaghi M., and Shafer R.W. Characterization of mutation spectra with ultra-deep pyrosequencing: application to HIV-1 drug resistance. Genome Res. 17 (2007) 1195-1201
141. Weiner A.J., Thaler M.M., Crawford K., Ching K., Kansopon J., Chien D.Y., Hall J.E., Hu F., and Houghton M. A unique, predominant hepatitis C virus variant found in an infant born to a mother with multiple variants. J. Virol. 67 (1993) 4365-4368
142. Wilke C.O. Quasispecies theory in the context of population genetics. BMC Evol. Biol. 5 (2005) 44
143. Wilson J.J., Polyak S.J., Day T.D., and Gretch D.R. Characterization of simple and complex hepatitis C virus quasispecies by heteroduplex gel shift analysis: correlation with nucleotide sequencing. J. Gen. Virol. 76 Pt 7 (1995) 1763-1771
144. Wyatt C.A., Andrus L., Brotman B., Huang F., Lee D.H., and Prince A.M. Immunity in chimpanzees chronically infected with hepatitis C virus: role of minor quasispecies in reinfection. J. Virol. 72 (1998) 1725-1730
145. Xing Y., and Lee C. Can RNA selection pressure distort the measurement of Ka/Ks?. Gene 370 (2006) 1-5
146. Yea C., Bukh J., Ayers M., Roberts E., Krajden M., and Tellier R. Monitoring of hepatitis C virus quasispecies in chronic infection by matrix-assisted laser desorption ionization-time of flight mass spectrometry mutation detection. J. Clin. Microbiol. 45 (2007) 1053-1057
147. Yuki N., Hayashi N., Moribe T., Matsushita Y., Tabata T., Inoue T., Kanazawa Y., Ohkawa K., Kasahara A., Fusamoto H., and Kamada T. Relation of disease activity during chronic hepatitis C infection to complexity of hypervariable region 1 quasispecies. Hepatology 25 (1997) 439-444